Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 09/54
Arlen
Specter
U.S. Senate · R-PA
Taken from pharma & insurers
$159,750
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 09/54
Pharma & Health$136,450
Insurers & HMOs$23,300
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 9 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$159,750
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Through the leadership PAC
Beyond the campaign account, a leadership PAC under Specter's control (Big Tent PAC) took $61,000 from banks, card lenders, drug makers and insurers.
Source: FEC; Big Tent PAC
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$136,450
Amgen$81,250
Johnson & Johnson$33,650
Merck$7,400
Pfizer$6,400
Bristol Myers Squibb$6,250
Eli Lilly$1,500
Insurers & HMOs$23,300
Cigna$17,000
Aetna$6,300